Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000248609 | SCV000311185 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001705368 | SCV000730058 | likely benign | not provided | 2019-08-23 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000248609 | SCV001338594 | likely benign | not specified | 2020-04-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001237896 | SCV001410683 | likely benign | RASopathy | 2024-12-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002401957 | SCV002708110 | likely benign | Cardiovascular phenotype | 2020-03-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |